4-[(4-nitrophenyl)amino]butanoic acid, 97%, 250mg

3,3'-Methylenebis[1-(2,6-diisopropylphenyl)-3-imidazolium Bromide]>98.0%(HPLC)(T)5g

Ethyl 5-chlorothiazolo[5,4-b]pyridine-2-carboxylate, 95.0%, 250mg

4-(2-Carboxy-1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid hydrochloride, 97%, 250mg

2-Propanol, mínimo 99,5 %, para síntesis, 2,5 l, envase de vidrio

2-(Hydroxymethyl)cyclopentanone, 95.0%, 5g

5-chloro-3-[(2-methoxyphenyl)methyl]-1,2,4-thiadiazole, 95.0%, 2g

2-(5-bromo-6-chloropyridin-3-yl)ethan-1-ol, 95.0%, 250mg

3-[(3-Methacrylamidopropyl)dimethylammonio]propane-1-sulfonate>98.0%(HPLC)25g

Methyl 4-Iodophenylacetate, 98.0%, 1g

4-(Aminomethyl)-3-methoxyphenol hydrochloride, 1g

(2E)-1-(3-bromophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

3-Methylbut-2-en-1-amine hydrochloride, 97%, 250mg